Biochip array technology allows the simultaneous detection of multiple analytes from a single undivided sample. Simultaneous immunoassays define discrete test regions on the biochip surface, which is also the vessel for the immunoreactions. This technology enables the comprehensive detection of veterinary drugs in milk, including all legislated antibiotics at or below the relevant regulatory requirements, which is important for consumer protection. The Infiniplex for Milk (IPM) biochip array, based on biochip array technology, allows the simultaneous screening of approximately 130 contaminants from a single undivided milk sample. This study reports the new application of IPM for the fast (under 19 min) multi-contaminant screening of milk samples using the fully automated biochip analyzer Evidence MultiSTAT. Simultaneous competitive chemiluminescent immunoassays, defining discrete test regions on the biochip surface, were employed and applied to the Evidence MultiSTAT analyzer. This system processes a self-contained cartridge with all the components required for the assays and has the capacity to assess 2 biochips in under 19 min. Raw milk samples (250 µL) was added directly to the biochips. The results are qualitative. Up to 130 authorized and unauthorized contaminants were detected (including antimicrobials, anti-inflammatories, anti-parasitics, corticosteroids, growth promoters and mycotoxins). The decision levels (concentration of contaminants resulting in > 95% of positive results) ranged from 0.04ppb (aflatoxin M1) to 150ppb (melamine). Assessment of natural incurred raw milk samples showed correlation > 90% with LC-MS/MS. Biochip array technology is applicable to the fast (under 19 min) multi-contaminant screening of milk samples when applied to the Evidence MultiSTAT analyzer. This offers a reliable analytical application to facilitate the comprehensive monitoring of contaminants in raw milk.